Description:
Home Page: tnfpharma.com
855 N. Wolfe Street
Baltimore,
MD
21205
United States
Phone:
856 848 8698
Officers
| Name | Title |
|---|---|
| Mr. Ian Rhodes CPA | Interim Chief Financial Officer |
| Dr. Mitchell Glass M.D. | President, Chief Medical Officer & Director |
| Robert Schatz | Investor Relations Officer |
| Dr. Jenna Brager M.S., Ph.D., R.N. | Executive Vice President of Drug Development |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2014-01-23 |
| Fiscal Year End: | December |
| Full Time Employees: | 6 |